Buformin

Revision as of 18:38, 27 September 2011 by WikiBot (talk | contribs) (Protected "Buformin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Buformin
Error creating thumbnail: File missing
Clinical data
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • Withdrawn in most countries
Pharmacokinetic data
ExcretionRenal
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC6H15N5
Molar mass157.217 g/mol

Buformin is an anti-diabetic drug of the biguanide class, chemically related to metformin and phenformin. It was withdrawn from the market in most countries due to a high risk of causing lactic acidosis.[1][2]

References

  1. Verdonck L, Sangster B, van Heijst A, de Groot G, Maes R (1981). "Buformin concentrations in a case of fatal lactic acidosis". Diabetologia. 20 (1): 45–6. PMID 7202882.
  2. Deppermann D, Heidland A, Ritz E, Hörl W (1978). "[Lactic acidosis--a possible complication in buformin-treated diabetics (author's transl)]". Klin Wochenschr. 56 (17): 843–53. PMID 713413.

Template:Oral hypoglycemics

Template:Pharma-stub

hu:Buformin